Advertise on podcast: BMJ's Coronavirus (COVID-19) playlist

In this second podcast focussing on the covid response in South Asia, we’re focussing on the intersection of conflict and covid in the region. The pandemic has highlighted the underlying weaknesses in many health systems - but could it also be used as a catalyst for change, and be a step towards easing tensions? To discuss this, Kamran Abbasi, executive editor of The BMJ, is joined by Zulfiqar Bhutta, head of the Institute for Global Health and Development, Aga Khan University, and Arun Mitra senior vice president of Indian Doctors for Peace & Development. To read more; Conflict, extremism, resilience and peace in South Asia; can covid-19 provide a bridge for peace and rapprochement? https://www.bmj.com/content/375/BMJ-2021-067384

Professor Roszalina Ramli, Department of oral and maxillofacial surgery, Universiti Kebangsaan Malaysia, Kuala Lumpur, is an oral and maxillofacial surgeon by training, who developed skills in biomechanics and epidemiology in order to solve what she saw as a major community problem. In this podcast, Dr Ramli tells Editor-in-Chief of Injury Prevention, Rod McClure, how she stepped from the operating theatre to research, and into public health policy. Please subscribe to the Injury Prevention Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please consider leaving us a review and a 5-star rating on the Injury Prevention Podcast iTunes page (https://podcasts.apple.com/gb/podcast/injury-prevention-podcast/id942473946). Thank you for listening!

Do hospitalised COVID-19 patients receiving treatment with CPAP and HFNOT present a significant added risk of viral contamination to the surrounding environment used by healthcare workers? And is there enough evidence to suggest or recommend levels of PPE that should be used for healthcare workers caring for patients on CPAP or HFNOT? Two of the main questions this short podcast addresses. Rachael Moses, Multimedia Editor Thorax BMJ, interviews Dr Chris Green, Consultant in Infectious Diseases & General (Internal) Medicine, University Hospitals Birmingham NHS Foundation Trust. Read the two related papers: SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures - https://thorax.bmj.com/content/early/2021/11/01/thoraxjnl-2021-218035 Coughs and sneezes spread diseases: but do ‘aerosol generating’ procedures? - https://thorax.bmj.com/content/early/2021/11/10/thoraxjnl-2021-218133

In this episode of the JIM Podcast, Editor-In-Chief Richard McCallum speaks with Dr. Sonja A. Rasmussen on the COVID-19 vaccine in children and pregnancy. Dr. Rasmussen is currently a Tenured Professor at the University of Florida in the Department of Pediatrics with a Joint Appointment at the Department of Epidemiology and Obstetrics and Gynecology. She has previously served as Deputy Director of Infectious Disease at the CDC, Acting Director of the Office of Health Preparedness and Response, Deputy Director of the Influenza Coordination Unit and Senior Scientist at the National Center on Birth Defects and Developmental Disabilities.

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, interviews Professor Andrew Chan, Harvard Medical School, Boston, USA. This podcast is focused on the paper "Diet quality and risk and severity of COVID-19: a prospective cohort study", published in paper copy in Gut in November 2021. Link to the paper: https://gut.bmj.com/content/70/11/2096

In this podcast series, Kamran Abbasi, executive editor of The BMJ will convene experts from South Asia to discuss how the pandemic has affected the region, how measures like lock-down and vaccination have been handled, and the impact of the pandemic on the social determinants of health. In this first podcast, we're focussing on India and Nepal, and are joined by; Srinath Reddy, president of the Public Health Foundation of India. Biraj Swain, who works in global development in Asia and East Africa, is a senior media critic and Buddha Basnyat, director of the Oxford University Clinical Research Unit in Nepal. For more covid coverage www.bmj.com/coronavirus

In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Dr Ash Clift Nuffield Department of Primary Care Health Sciences, University of Oxford. The evidence surrounding COVID-19 has been conflicting and inconsistent. This podcast discusses the findings of this observational and Mendelian randomisation study using the UK Biobank cohort. The author discusses the findings with regards to the potential causal effect of cigarette smoking on the severity of COVID-19 infection and what this means for both the public and clinicians. Related article: https://thorax.bmj.com/content/thoraxjnl/early/2021/09/12/thoraxjnl-2021-217080

This week our regular panelists, Helen Macdonald and Joe Ross, are joined by Juan Franco, editor in chief of BMJ Evidence Based Medicine - to take a primary care focussed look at what's been happening in the world of evidence. On this week’s episode. As kids go back to school, winter bugs surge and pressure mounts on health services we look at two trials which aimed to use reduce antibiotic prescribing for respiratory tract infections in nursing homes and primary care Juan brings us an update on prescribing medicinal cannabis for pain, based on a recent BMJ rapid recommendation article and linked systematic review and meta-analysis And finally, in covid news, how likely are you to be admitted or die from covid after one or two SARS-CoV 2 vaccinations? Reading list Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents - https://www.bmj.com/content/374/bmj.n2198 Procalcitonin and lung ultrasonography point-of-care testing to determine antibiotic prescription in patients with lower respiratory tract infection in primary care - https://www.bmj.com/content/374/bmj.n2132 Medical cannabis or cannabinoids for chronic pain - https://www.bmj.com/content/374/bmj.n2040 Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination - https://www.bmj.com/content/374/bmj.n2244

An outlook at how disabled lives have been affected by the COVID-19 pandemic and, in particular, by the current vaccine roll-out. Alice Wong, a disabled activist, and Alyssa Burgart, an anesthesiologist and ethicist at Stanford University, tell Medical Humanities' Editor-in-Chief, Brandy Schillace, how disabled lives have been overlooked in this crisis, as the very systems and designs of medicine cater to the able-bodied. Read the transcript on the Medical Humanities blog (https://blogs.bmj.com/medical-humanities/2021/08/12/medicines-disability-blind-spot-privilege-access-and-the-continued-vaccine-roll-out). You can subscribe to the Medical Humanities podcast on any of the main platforms to get the latest episodes. If you enjoy the show, please consider leaving us a review or a comment on the Medical Humanities Podcast iTunes page (https://podcasts.apple.com/gb/podcast/medical-humanities-podcast/id961667204). Thank you.

In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272 https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to Covid-19. Abigail Davis, GP and section editor, covers the latest evidence around vaccine immunogenicity in different immunosuppressed populations, as well as the use of interleukin-6 inhibitors in COVID-19 patients. And Emma Scott, section editor, updates us on mucormycosis, or black fungus infection in COVID-19 patients. For more, see: BMJ Best Practice's topic on COVID-19: bestpractice.bmj.com/topics/en-gb/3000168 BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): new-learning.bmj.com/course/10065100 BMJ Learning COVID-19 in primary care module: new-learning.bmj.com/course/10065230 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00676-0/fulltext Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2100433 WHO Therapeutics and COVID-19: living guideline: https://app.magicapp.org/#/guideline/nBkO1E/section/LrV7OL Indian Council of Medical Research advice on mucormycosis: https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY_FROM_ICMR_In_COVID19_time.pdf

Medical Humanities' Editor-in-Chief, Brandy Schillace, talks to Dr. Eleanor Janega, a medieval historian, about comparisons between COVID-19 and the Black Death. Read the blog post, which includes the transcript of the podcast, here: https://blogs.bmj.com/medical-humanities/2021/07/15/going-medieval-historical-comparisons-of-plague-and-pandemic/